PHARMOPTIMA

Serial Number 87377697
Registration 5342732
702

Registration Progress

Application Filed
Mar 20, 2017
Under Examination
Sep 12, 2017
Approved for Publication
Jul 18, 2017
Published for Opposition
Jul 18, 2017
Registered
Nov 21, 2017

Trademark Image

PHARMOPTIMA

Basic Information

Serial Number
87377697
Registration Number
5342732
Filing Date
March 20, 2017
Registration Date
November 21, 2017
Published for Opposition
July 18, 2017
Drawing Code
3

Status Summary

Current Status
Active
Status Code
702
Status Date
Jun 1, 2023
Registration
Registered
Classes
042

Rights Holder

Genesis PharmOptima, LLC

16
Address
Law Department
2439 Kuser Rd
hamilton, NJ 08691

Ownership History

Genesis PharmOptima, LLC

Original Applicant
16
Hamilton, NJ

Genesis PharmOptima, LLC

Owner at Publication
16
Hamilton, NJ

Genesis PharmOptima, LLC

Original Registrant
16
hamilton, NJ

Legal Representation

Attorney
Christina E. Brule

USPTO Deadlines

Next Deadline
702 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20171121)
Due Date
November 21, 2027
Grace Period Ends
May 21, 2028

Application History

25 events
Date Code Type Description Documents
Sep 15, 2023 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Sep 15, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 15, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 15, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 1, 2023 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 1, 2023 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 1, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 21, 2022 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Nov 21, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Nov 21, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 19, 2017 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 18, 2017 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 25, 2017 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 12, 2017 IUAF S USE AMENDMENT FILED Loading...
Sep 25, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 12, 2017 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 12, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 18, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 18, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 28, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 13, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 13, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 24, 2017 MDSM E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Mar 23, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 23, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development
First Use Anywhere: Apr 1, 2017
First Use in Commerce: Apr 1, 2017

Additional Information

Design Mark
The mark consists of he literal phrase "PharmOptima". The letter "O" is depicted as the iris and pupil of an eye. Two arches of circles of varying sizes extend above and below the literal phrase "PharmOptima" connecting the letter "R" and the letter "P".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
PHARM OPTIMA

Classification

International Classes
042